I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 3 studies | 28% ± 14% | |
| astrocyte | 3 studies | 40% ± 14% | |
| interneuron | 3 studies | 46% ± 22% | |
| oligodendrocyte | 3 studies | 29% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 3 studies | 28% ± 14% | |
| astrocyte | 3 studies | 40% ± 14% | |
| interneuron | 3 studies | 46% ± 22% | |
| oligodendrocyte | 3 studies | 29% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 33% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 100% | 4564.71 | 89 / 89 | 39% | 1.02 | 348 / 901 |
| esophagus | 100% | 3896.55 | 1440 / 1445 | 4% | 0.05 | 7 / 183 |
| liver | 100% | 9550.87 | 226 / 226 | 3% | 0.04 | 13 / 406 |
| lung | 100% | 3130.09 | 578 / 578 | 2% | 0.03 | 21 / 1155 |
| brain | 99% | 2259.09 | 2616 / 2642 | 2% | 0.03 | 17 / 705 |
| bladder | 100% | 3102.71 | 21 / 21 | 1% | 0.02 | 7 / 504 |
| breast | 100% | 3274.27 | 459 / 459 | 1% | 0.02 | 11 / 1118 |
| uterus | 100% | 5610.09 | 170 / 170 | 1% | 0.01 | 4 / 459 |
| skin | 100% | 2854.66 | 1808 / 1809 | 1% | 0.01 | 4 / 472 |
| prostate | 100% | 5324.04 | 245 / 245 | 1% | 0.01 | 3 / 502 |
| pancreas | 100% | 2409.14 | 328 / 328 | 1% | 0.01 | 1 / 178 |
| adipose | 100% | 3447.77 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| adrenal gland | 100% | 4008.04 | 258 / 258 | 0% | 0 | 0 / 230 |
| ovary | 100% | 5207.45 | 180 / 180 | 0% | 0 | 0 / 430 |
| spleen | 100% | 3599.63 | 241 / 241 | 0% | 0 | 0 / 0 |
| thymus | 100% | 3888.14 | 653 / 653 | 0% | 0 | 0 / 605 |
| intestine | 100% | 3788.94 | 964 / 966 | 0% | 0.00 | 1 / 527 |
| blood vessel | 100% | 4107.40 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 2754.85 | 855 / 861 | 0% | 0 | 0 / 0 |
| stomach | 97% | 2227.26 | 350 / 359 | 2% | 0.03 | 5 / 286 |
| muscle | 80% | 862.05 | 640 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 35% | 683.41 | 328 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006635 | Biological process | fatty acid beta-oxidation |
| GO_0033539 | Biological process | fatty acid beta-oxidation using acyl-CoA dehydrogenase |
| GO_0031966 | Cellular component | mitochondrial membrane |
| GO_0005743 | Cellular component | mitochondrial inner membrane |
| GO_0005777 | Cellular component | peroxisome |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005634 | Cellular component | nucleus |
| GO_0004466 | Molecular function | long-chain fatty acyl-CoA dehydrogenase activity |
| GO_0003995 | Molecular function | acyl-CoA dehydrogenase activity |
| GO_0017099 | Molecular function | very-long-chain fatty acyl-CoA dehydrogenase activity |
| GO_0050660 | Molecular function | flavin adenine dinucleotide binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0070991 | Molecular function | medium-chain fatty acyl-CoA dehydrogenase activity |
| Gene name | ACAD11 |
| Protein name | ACAD11 protein Acyl-CoA dehydrogenase family member 11 (ACAD-11) (EC 1.3.8.-) Acyl-CoA dehydrogenase family member 11 |
| Synonyms | |
| Description | FUNCTION: Acyl-CoA dehydrogenase, that exhibits maximal activity towards saturated C22-CoA . Probably participates in beta-oxydation and energy production but could also play a role in the metabolism of specific fatty acids to control fatty acids composition of cellular lipids in brain (Probable). . |
| Accessions | ENST00000510100.1 Q08AE9 D6RDI8 F8WEV0 ENST00000485198.5 ENST00000264990.11 [Q709F0-1] ENST00000481970.2 H0Y9C6 Q709F0 |
